Patents by Inventor Masoud Fakhr TAVAZOIE

Masoud Fakhr TAVAZOIE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING CANCER
    Publication number: 20220331274
    Abstract: The invention features methods of treating cancer with 2-[3-[(3R)-3-[[2-chloro-3-(trifluoromethyl)phenyl]methyl-(2,2-diphenylethyl)amino]butoxy]phenyl]acetic acid. The disclosure also provides methods of treating cancer including combinations of 2-[3-[(3R)-3-[[2-chloro-3-(trifluoromethyl)phenyl]methyl-(2,2-diphenylethyl)amino]butoxy]phenyl]acetic acid and additional anti-cancer therapies.
    Type: Application
    Filed: September 10, 2020
    Publication date: October 20, 2022
    Inventors: Masoud Fakhr TAVAZOIE, Robert WASSERMAN, David M. DARST, Jr.
  • METHODS OF TREATING CANCER
    Publication number: 20210177790
    Abstract: The invention features methods of treating cancer with ?-GPA. The disclosure also provides methods of treating cancer including combinations of ?-GPA and additional anti-cancer therapies.
    Type: Application
    Filed: December 11, 2020
    Publication date: June 17, 2021
    Inventors: Masoud Fakhr TAVAZOIE, David M. DARST, JR., Foster Casimir GONSALVES, Isabel KURTH
  • LXR agonists and uses thereof
    Patent number: 10669296
    Abstract: This invention features compounds that modulate the activity of liver X receptors, pharmaceutical compositions including the compounds of the invention, and methods of utilizing those compositions for modulating the activity of liver X receptors in the treatment of cancer.
    Type: Grant
    Filed: January 9, 2015
    Date of Patent: June 2, 2020
    Assignee: Rgenix, Inc.
    Inventors: Eduardo J. Martinez, Bernd Kaiser, Sohail F. Tavazoie, Isabel Kurth, Foster Casimir Gonsalves, David M. Darst, Jr., Masoud Fakhr Tavazoie
  • TREATMENT AND DIAGNOSIS OF CANCER
    Publication number: 20190125745
    Abstract: This invention features compounds that modulate the activity of liver X receptors, pharmaceutical compositions including the compounds of the invention, and methods of utilizing those compositions for modulating the activity of liver X receptors for the treatment of cancer.
    Type: Application
    Filed: December 17, 2015
    Publication date: May 2, 2019
    Inventors: Eduardo J. MARTINEZ, Masoud Fakhr Tavazoie
  • LXR AGONISTS AND USES THEREOF
    Publication number: 20170066791
    Abstract: This invention features compounds that modulate the activity of liver X receptors, pharmaceutical compositions including the compounds of the invention, and methods of utilizing those compositions for modulating the activity of liver X receptors in the treatment of cancer.
    Type: Application
    Filed: January 9, 2015
    Publication date: March 9, 2017
    Inventors: Eduardo J. MARTINEZ, Bernd KAISER, Sohail F TAVAZOIE, Isabel KURTH, Foster Casimir GONSALVES, David M. DARST, Masoud Fakhr TAVAZOIE